Patents by Inventor Albert H. Meier

Albert H. Meier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
    Patent number: 5344832
    Abstract: A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabetes)--by administration to a vertebrate, animal or human, of a dopamine agonist and a prolactin stimulator. The dopamine agonist and prolactin stimulator are administered in daily dosages, respectively, at a time of day dependent on the normal circadian rhythm of fat and lean members of a similar species. Decreases in body fat deposits result by treatment of an obese species on a daily timed sequence based on circadian rhythms of the peak prolactin, or peak prolactin and peak glucocorticosteroid, blood level established for lean insulin sensitive members of a similar species.
    Type: Grant
    Filed: June 24, 1991
    Date of Patent: September 6, 1994
    Assignees: The Board of Supervisors of Louisiana University and Agricultural and Mechanical College, Ergo Science Incorporated
    Inventors: Anthony H. Cincotta, Albert H. Meier
  • Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
    Patent number: 5006526
    Abstract: A method for the treatment of conditions associated with atherosclerosis in vertebrate animals, particularly man. A prolactin-inhibiting compound administered to the animal exhibiting the atherosclerotic conditions, in dosage sufficient to decrease the total plasma cholesterol and total triglyceride levels, will over a sufficient period of time suppress atherosclerosis and reduce lipid plaques in the walls of the blood vessels of the animal. Exemplary of prolactin-inhibiting compounds are the ergot-related drugs 2-bromo-alpha-ergocryptine, 6-methyl-8 beta-carbobenzyloxy-aminomethyl-10 alpha-ergoline, 1,6-dimethyl-8 beta-carbobenzyloxy-aminomethyl-10 alpha-ergoline, 8-acylaminoergolenes, ergocornine, 9,10-dihydroergocornine, and D-2-halo-6-alkyl-8-substituted ergolines.
    Type: Grant
    Filed: October 17, 1988
    Date of Patent: April 9, 1991
    Assignee: Louisiana State University
    Inventors: Albert H. Meier, Anthony H. Cincotta, Donn D. Martin
  • Method of inhibiting body fat stores
    Patent number: 4783469
    Abstract: Methods for reducing body fat stores in vertebrate animals by administering a prolactin-inhibitor to the animal in a chosen dose which effects such reduction with or without a concomitant decrease in body weight is disclosed.
    Type: Grant
    Filed: August 13, 1987
    Date of Patent: November 8, 1988
    Inventors: Albert H. Meier, Anthony H. Cincotta
  • Method of inhibiting body fat stores
    Patent number: 4749709
    Abstract: A method for reducing body fat stores in vertebrate animals by administer a prolactin-inhibitor to the animal in a dose which effects such reduction without a concomitant decrease in body weight is disclosed.
    Type: Grant
    Filed: April 17, 1987
    Date of Patent: June 7, 1988
    Assignee: Louisiana State University and Agricultural and Mechanical College
    Inventors: Albert H. Meier, Anthony H. Cincotta
  • Method of inhibiting body fat stores
    Patent number: 4659715
    Abstract: A method for reducing body fat stores in vertebrate animals by administer a prolactin-inhibitor to the animal in a dose which effects such reduction without a concomitant decrease in body weight is disclosed.
    Type: Grant
    Filed: March 7, 1986
    Date of Patent: April 21, 1987
    Assignee: Louisiana State University and Agricultural and Mechanical College
    Inventors: Albert H. Meier, Anthony H. Cincotta